Phenyl-substituted pyrimidine derivatives as mGluR antagonists
US7642264B2 · kind B2 · utility
5Cited by
0References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2007 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Aug 1, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (Ia), a process for the manufacture thereof, pharmaceutical compositions containing them, and their use for treating CNS disorders:wherein A, B, R1, R2, R3 and R4 are as defined in the description and claims.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.